| 000 | 01488 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515052455.0 | ||
| 264 | 0 | _c20070327 | |
| 008 | 200703s 0 0 eng d | ||
| 022 | _a1470-2045 | ||
| 024 | 7 |
_a10.1016/S1470-2045(06)71014-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBader, Arnim A | |
| 245 | 0 | 0 |
_aAnhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. _h[electronic resource] |
| 260 |
_bThe Lancet. Oncology _cJan 2007 |
||
| 300 |
_a79-81 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOligohydramnios _xchemically induced |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy Complications, Neoplastic _xdrug therapy |
| 650 | 0 | 4 | _aTrastuzumab |
| 700 | 1 | _aSchlembach, Dietmar | |
| 700 | 1 | _aTamussino, Karl F | |
| 700 | 1 | _aPristauz, Gunda | |
| 700 | 1 | _aPetru, Edgar | |
| 773 | 0 |
_tThe Lancet. Oncology _gvol. 8 _gno. 1 _gp. 79-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(06)71014-2 _zAvailable from publisher's website |
| 999 |
_c16763313 _d16763313 |
||